Curbing high drug prices is an issue that cuts across all political lines.
In a new GHN Commentary, Della “Trip” Stoner says it’s time for Congress to act on the issue.
She gives the example of insulin, which is used by people with diabetes. “The price of insulin has increased 700 percent over the last 20 years and from 2012 to 2016, annual per-person spending on insulin by patients with type-1 diabetes nearly doubled, from $2,900 to $5,700 per year,’’ she writes.
Stoner supports legislation that would lower drug prices, a proposal she says would save patients and taxpayers billions of dollars.